Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus

Journal of Clinical Microbiology

Volumn 43, Issue 10, 2005, Pages 5285-5287

  Hayden, M K ^a   Rezai, K ^a,b   Hayes, R A ^a   Lolans, K ^b   Quinn, J P ^a,b   Weinstein, R A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Jr Hospital of Cook County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ARTHRITIS; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CASE REPORT; FEMALE; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OSTEOMYELITIS; PRIORITY JOURNAL; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; LUMBAR VERTEBRAE; LUMBOSACRAL REGION; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OSTEOMYELITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT FAILURE;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 26944497198     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.10.5285-5287.2005     Document Type: Article

References (14)

1. Akins, R. L., and M. J. Rybak. 2001. Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob. Agents Chemother. 45:454-459.
2. Cubist Pharmaceuticals, Inc. 2003. Daptomycin (Cubicin) package literature. Cubist Pharmaceuticals, Inc., Lexington, Mass.
3. Cubist Pharmaceuticals, Inc. Daptomycin in the treatment of subjects with infective endocarditis or bacteremia due to S. aureus. ClinicalTrials.gov, identifier NCT00093067. [Online.] http://clinicaltrials.gov/show/NCT00093067.
4. Mader, J. T., and K. Adams. 1989. Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits. Antimicrob. Agents Chemother. 33:689-692.
5. Mangili, A., I. Bica, D. R. Snydman, and D. H. Hamer. 2005. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin. Infect. Dis. 40:1058-1060.
6. Matushek, M. G., M. J. Bonten, and M. K. Hayden. 1996. Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. J. Clin. Microbiol. 34:2598-2600.
7. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity. Approved standard M26-A. Clinical and Laboratory Standards Institute, Wayne, Pa.
8. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 6th ed., M7-A6. Clinical and Laboratory Standards Institute, Wayne, Pa.
9. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial disk susceptibility tests. Approved standard, 8th ed., M2-A8. Clinical and Laboratory Standards Institute, Wayne, Pa.
10. Silverman, J. A., N. Oliver, O. Andrew, and T. Li. 2001. Resistance studies with daptomycin. Antimicrob. Agents Chemother. 45:1799-1802.
11. Stienecker, S., and G. Sriramenini. 2004. Use of daptomycin for osteomyelitis in Lima, Ohio. OPAT Newsl. 4(2). [Online.] http://www.opat.com /Articles/September/Stienecker.htm. Accessed 28 March 2005.
12. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. E. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
13. Todar, K. 2002. Growth of bacterial populations. In Todar's online textbook of bacteriology. [Online.] http://textbookofbacteriology.net/growth. html. Accessed 10 September 2004.
14. Walsh, T. R., A. Bolmstrom, A. Qwarnstrom, P. Ho, M. Wootton, R. A. Howe, A. P. MacGowan, and D. Diekema. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2439-2444.